Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.1B |
| 2 |
NVIDIA
NVDA
|
+$737M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$651M |
| 4 |
Advanced Micro Devices
AMD
|
+$570M |
| 5 |
Marvell Technology
MRVL
|
+$500M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.04B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.34B |
| 3 |
Coinbase
COIN
|
+$1.22B |
| 4 |
Arthur J. Gallagher & Co
AJG
|
+$569M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$517M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.05% |
| 2 | Consumer Discretionary | 1.31% |
| 3 | Financials | 1.07% |
| 4 | Industrials | 0.93% |
| 5 | Healthcare | 0.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8351
ECB Bancorp
ECBK
$175M
| $200K | ﹤0.01% |
+13,224
| New | +$191K |
|
8352
CALL
Schwab US Broad Market ETF
SCHB
$44.9B
| $200K | ﹤0.01% |
+9,300
| New | +$212K |
|
8353
Avantis All International Markets Equity ETF
AVNM
$721M
| $200K | ﹤0.01% |
3,433
-47,643
| -93% | -$2.73M |
|
8354
Simplify Hedged Equity ETF
HEQT
$304M
| $200K | ﹤0.01% |
7,003
-8,351
| -54% | -$247K |
|
8355
PUT
Crescent Energy
CRGY
$4.07B
| $200K | ﹤0.01% |
17,800
+6,600
| +59% | +$90.9K |
|
8356
Champions Oncology
CSBR
$71.4M
| $200K | ﹤0.01% |
+23,020
| New | +$233K |
|
|
DDL
8357
Dingdong
DDL
$512M
| $200K | ﹤0.01% |
73,994
-163,928
| -69% | -$534K |
|
|
MCHB
8358
Mechanics Bancorp
MCHB
$3.73B
| $199K | ﹤0.01% |
16,952
-39,846
| -70% | -$395K |
|
8359
Solid Power
SLDP
$557M
| $198K | ﹤0.01% |
+189,041
| New | +$259K |
|
|
QETH
8360
Invesco Galaxy Ethereum ETF
QETH
$17M
| $198K | ﹤0.01% |
10,880
-35,633
| -77% | -$936K |
|
8361
Virtus Duff & Phelps Clean Energy ETF
VCLN
$5.65M
| $198K | ﹤0.01% |
+11,880
| New | +$202K |
|
|
FFAI
8362
CALL
Faraday Future Intelligent Electric
FFAI
$10.8M
| $198K | ﹤0.01% |
1,170
-3,222
| -73% | -$724K |
|
8363
CALL
Gevo
GEVO
$405M
| $198K | ﹤0.01% |
170,900
+27,500
| +19% | +$46.1K |
|
8364
N-able
NABL
$601M
| $198K | ﹤0.01% |
27,936
-2,482
| -8% | -$22.1K |
|
8365
PUT
Ocular Therapeutix
OCUL
$2.06B
| $198K | ﹤0.01% |
27,000
+3,700
| +16% | +$28.4K |
|
8366
Richardson Electronics
RELL
$297M
| $198K | ﹤0.01% |
+17,720
| New | +$230K |
|
8367
Neumora Therapeutics
NMRA
$309M
| $197K | ﹤0.01% |
197,030
+172,876
| +716% | +$296K |
|
8368
CALL
RXO
RXO
$3.52B
| $197K | ﹤0.01% |
+10,300
| New | +$225K |
|
8369
PUT
Arrowhead Research
ARWR
$12.6B
| $196K | ﹤0.01% |
15,400
-14,900
| -49% | -$271K |
|
|
FAZ
8370
Direxion Daily Financial Bear 3x ETF
FAZ
$85.8M
| $196K | ﹤0.01% |
3,483
-333
| -9% | -$19K |
|
|
ESSA
8371
DELISTED
ESSA Bancorp
ESSA
| $196K | ﹤0.01% |
+10,381
| New | +$210K |
|
8372
PUT
Sibanye-Stillwater
SBSW
$7.55B
| $196K | ﹤0.01% |
42,700
-17,400
| -29% | -$66K |
|
|
WMPN
8373
DELISTED
William Penn Bancorporation Common Stock
WMPN
| $195K | ﹤0.01% |
+17,879
| New | +$211K |
|
8374
CALL
Arbutus Biopharma
ABUS
$919M
| $195K | ﹤0.01% |
+55,900
| New | +$186K |
|
8375
PUT
LifeMD
LFMD
$172M
| $195K | ﹤0.01% |
35,800
+25,700
| +254% | +$146K |
|
Similar funds
Jane Street's Q1 2025 Portfolio in Review
As of Q1 2025, Jane Street held 11,142 positions worth $397B, down 14% from $460B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Jane Street withdrew a net $28.5B in Q1 2025, closing 1,903 positions and reducing 3,315 holdings. Its most notable exit was VanEck Gold Miners ETF, an estimated $246M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.2% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jane Street opened a new position in CoreWeave worth $349M.
- Jane Street's largest Q1 2025 buy was CoreWeave: 9,401,943 shares worth $349M.
- Jane Street added most to Broadcom in Q1 2025, an estimated $1.1B increase.
- Jane Street's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.04B.
- Jane Street fully exited VanEck Gold Miners ETF in Q1 2025, selling an estimated $246M.
- Jane Street's ten largest holdings make up 38% of its $397B portfolio in Q1 2025.
- Jane Street opened 1,813 new positions and closed 1,903 in Q1 2025.
- Jane Street's portfolio value fell 14% quarter-over-quarter to $397B.
Based on Jane Street's 13F filing for Q1 2025, filed 14 May 2025.